Study title:
Min B*,Song D,Khayksi V,Zhang S,Choma N,Koss-Twardy S, An Open-label Study of the Safety of Flumazenil when Used in Children to Reverse the Residual Effects of Benzodiazepine-Induced Conscious Sedation-Bioanalytical Results, 02.12.94
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Nervous System Diseases
|
Brands: Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: FLUMAZENIL |
ATC code: |
Document link:
|
Document date:
|
Study number: N0137040 |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|